Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00202293Phase 4Completed
A Phase 4 trial of olanzapine in bipolar disorder (BD), schizoaffective disorder, sponsored by Melbourne Health. Started Oct 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00202293.